Regal Investment Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-10,262
Closed -$1.31M 559
2022
Q4
$1.31M Sell
10,262
-10
-0.1% -$1.16K 0.13% 157
2022
Q3
$1.07M Buy
10,272
+57
+0.6% +$6.25K 0.11% 172
2022
Q2
$1.07M Buy
+10,215
New +$1.21M 0.11% 172
2015
Q4
Sell
-206
Closed -$18K 896
2015
Q3
$18K Hold
206
﹤0.01% 582
2015
Q2
$21K Buy
206
+131
+175% +$14.5K 0.01% 551
2015
Q1
$9K Buy
75
+63
+525% +$7.19K ﹤0.01% 711
2014
Q4
$1K Hold
12
﹤0.01% 897
2014
Q3
$1K Hold
12
﹤0.01% 924
2014
Q2
$1K Hold
12
﹤0.01% 887
2014
Q1
$1K Hold
12
﹤0.01% 869
2013
Q4
$1K Sell
12
-42
-78% -$3.63K ﹤0.01% 803
2013
Q3
$4K Hold
54
﹤0.01% 741
2013
Q2
$4K Buy
+54
New +$4.04K ﹤0.01% 733

Other funds holding ZBH

Regal Investment Advisors's ZBH Position: Q1 2023 in Review

Regal Investment Advisors sold out of Zimmer Biomet (ZBH) in Q1 2023, closing a stake of 10,262 shares — an estimated $1.31M sold.

Regal Investment Advisors first reported a position in ZBH in Q2 2013 and held it in 13 quarters. The position peaked at $1.31M in Q4 2022. 993 funds tracked by Wall St. Rank hold ZBH as of Q1 2023.

  • Regal Investment Advisors reported no remaining Zimmer Biomet position as of Q1 2023 after selling out during the quarter.
  • Regal Investment Advisors sold 10,262 Zimmer Biomet shares in Q1 2023, an estimated $1.31M.
  • Regal Investment Advisors first reported a position in Zimmer Biomet in Q2 2013 and held it in 13 quarters.
  • Regal Investment Advisors's Zimmer Biomet position peaked at $1.31M in Q4 2022.
  • 993 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2023.

Based on Regal Investment Advisors's 13F filing for Q1 2023, filed 11 May 2023.